ETON PHARMACEUTICALS INC. - COMMON STOCK
12.85
10-一月-25 12:05:13
15 分钟延时
股票
+0.84
+6.99%
今日范围
11.63 - 12.90
ISIN
N/A
来源
NASDAQ
-
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
03 1月 2025 05:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
20 12月 2024 05:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial
17 12月 2024 05:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
03 12月 2024 05:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
25 11月 2024 05:50:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
12 11月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)
07 11月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
06 11月 2024 15:30:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
03 10月 2024 05:30:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
22 8月 2024 15:30:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
08 8月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
30 7月 2024 16:30:00 条件 Nasdaq GlobeNewswire
-
15 7月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
09 5月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
01 5月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
30 4月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
29 4月 2024 15:30:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
22 3月 2024 01:00:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
14 3月 2024 15:01:00 条件 Nasdaq GlobeNewswire
-
29 2月 2024 15:01:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >